Cited by 505Inflammatory Bowel DiseaseSmoking Behavior and CessationMicroscopic Colitis

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Transdermal Nicotine for Active Ulcerative Colitis

Pullan, Rupert D., Rhodes, John, Ganesh, Subramanian, Mani, Venk, Morris, John S., Williams, Geraint T., Newcombe, Robert G., Russell, Michael, Feyerabend, Colin, Thomas, Gareth, Sawe, Urbain·1994·New England Journal of Medicine

DOI 10.1056/nejm199403243301202

Open this paper in CoChat — free account

Abstract

BACKGROUND: Ulcerative colitis is largely a disease of nonsmokers. Because anecdotal reports suggest that smoking and nicotine may improve the symptoms of the disease, we examined the effect of nicotine as a supplemental treatment for ulcerative colitis. METHODS: We treated 72 patients with active ulcerative colitis with either transdermal nicotine patches or placebo patches for six weeks in a randomized, double-blind study. Incremental doses of nicotine were given; most patients tolerated doses of 15 to 25 mg per 24 hours. All the patients had been taking mesalamine, and 12 were receiving low doses of glucocorticoids; these medications were continued without change during the study. Clinical, sigmoidoscopic, and histologic assessments were made at base line and at the end of the study; symptoms were recorded daily on a diary card, and the clinician made a global assessment. Side effects and plasma nicotine and cotinine concentrations were monitored throughout the study. RESULTS: Seventeen of the 35 patients in the nicotine group had complete remissions, as compared with 9 of the 37 patients in the placebo group (P = 0.03). The patients in the nicotine group had greater improvement in the global clinical grade of colitis (P < 0.001) and the histologic grade (P = 0.03), lower stool frequency (a difference of 1.6 stools daily; P = 0.008), less abdominal pain (P = 0.05), and less fecal urgency (P = 0.009). More patients in the nicotine group had side effects (23, vs. 11 in the placebo group; P = 0.002), the most common of which were nausea, lightheadedness, headache, and sleep disturbance. Withdrawals due to ineffective therapy were more common in the placebo group (3 vs. 8, P = 0.12). CONCLUSIONS: The addition of transdermal nicotine to conventional maintenance therapy improves symptoms in patients with ulcerative colitis.

Integrity signals

Registry

Crossref · 10.1056/nejm199403243301202

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statistical Methods for Rates and Proportions, 2nd ed
GROVE, W. A. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.12.1644-a · Cited by 3,756
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,793
Comparison of tests used to distinguish smokers from nonsmokers
Jarvis, M. J., Tunstall-Pedoe, H., Feyerabend, C., Vesey, C., & Saloojee, Y. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.11.1435 · Cited by 994
Self-citation
Variation Between Observers in Describing Mucosal Appearances in Proctocolitis
Baron, J. H., Connell, A. M., & Lennard‐Jones, J. E. (1964) · BMJ · doi:10.1136/bmj.1.5375.89 · Cited by 607
Daily intake of nicotine during cigarette smoking
Benowitz, N. L., & Jacob, P. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.67 · Cited by 502
Biopsy Studies in Ulcerative Colitis
Truelove, S. C., & Richards, W. C. D. (1956) · BMJ · doi:10.1136/bmj.1.4979.1315 · Cited by 394
Non-smoking: a feature of ulcerative colitis.
Harries, A. D., Baird, A., & Rhodes, J. (1982) · BMJ · doi:10.1136/bmj.284.6317.706 · Cited by 328
Self-citation
A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids
Feyerabend, C., & Russell, M. A. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb06592.x · Cited by 309
Self-citation
A Double-Blind Trial of a 16-Hour Transdermal Nicotine Patch in Smoking Cessation
Tønnesen, P., Nørregaard, J., Simonsen, K., & Säwe, U. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250503 · Cited by 296
Cigarette Smoking: A Dependence on High-Nicotine Boli
Russell, M. A. H., & Feyerabend, C. (1978) · Drug Metabolism Reviews · doi:10.3109/03602537808993776 · Cited by 253
Self-citation

Show all 28 references

Research works printed but not linked: 6

Roberts CJ, 1982, BMJ, 285, 440
Srivastava ED, 1991, Eur J Gastroenterol, 3, 815
Allen A, Bell A, McQueen S. Mucus and mucosal protection. In: Allen A, Flemstrom G, Garner A, Silen W, Turnberg LA, eds. Mechanisms of mucosal protection in the upper gastrointestinal tract. New York: Raven Press, 1984:195-201.
Cope GF, 1986, Gut, 27, A618
Dubois JP, 1989, Methods Find Exp Clin Pharmacol, 11, 187
Russell MAH. Nicotine intake and its control over smoking. In: Wonnacott S, Russell MAH, Stolerman IP, eds. Nicotine psychopharmacology: molecular, cellular, and behavioural aspects. Oxford, England: Oxford University Press, 1990:374-418.

Sorted by citations

Items 401–500 of 505

Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 7.0)
Blumenstein, I., Schnoy, E., Atreya, R., Bettenworth, D., de Laffolie, J., Kaltz, B., Kienle, P., Langhorst, J., Maaser, C., Ockenga, J., et al. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2769-2192 · Cited by 2
La rectite réfractaire
Godeberge, P. (2010) · Springer eBooks · doi:10.1007/978-2-8178-0097-4_1 · Cited by 2
Development of Modified Release Nicotine Tablet Formulation for Treatment of Ulcerative Colitis
Al-hurr, M. Y. (2017) · Iraqi Journal of Pharmaceutical Sciences · doi:10.31351/vol19iss2pp75-81 · Cited by 2
Gas-Therapy in Rheumatoid Arthritis Treatment: When West Meets East – Actual Medical Concepts with Ancient World Ideas
Gajewski, M., Maśliński, S., Rzodkiewicz, P., & Wojtecka-Lukasik, E. (2013) · InTech eBooks · doi:10.5772/54506 · Cited by 2
Ulcerative colitis in young adults
Kam, L. Y. (1998) · Postgraduate Medicine · doi:10.3810/pgm.1998.01.271 · Cited by 2
[The effect of cholinergic stimulation on autonomic balance and immune response in patients with chronic heart failure].
Biel, B., Jankowska, E. A., Banasiak, W., & Ponikowski, P. P. (2007) · PubMed · Cited by 2
Medical management of ulcerative colitis
Sandborn, W. J. (2007) · Springer eBooks · doi:10.1007/0-387-25808-6_30 · Cited by 2
Pneumo-Renal Syndrome in Anti- Neutrophil Cytoplasm Antibody (ANCA)-Associated Small-Vessel Vasculitis.
Andreiana, I., Stancu, S. H., Avram, A., Taran, L., & Mircescu, G. (2015) · Europe PMC (PubMed Central) · Cited by 2
Clinical Characteristic of Inflammatory Bowel Disease Diagnosed in Kurdistan Center for Gastroenterology and Hepatology (Kcgh) – Asulaimaiyah-Iraqi Kurdistan-Iraq
Alshekhani, M., Salim, B., Mohialdeen, Z. N., & Amin, B. J. H. (2020) · Gastroenterology Hepatology & Digestive Disorders · doi:10.33425/2639-9334.1050 · Cited by 3
ULCERATIVE COLITIS: THE MODERN VIEW OF ETIOLOGY AND PATHOGENESIS (literature review)
Сатырова, Т. В., & Михайлова, Е. И. (2010) · Health and Ecology Issues · doi:10.51523/2708-6011.2010-7-2-1 · Cited by 2
Smoking and the digestive system
Kamada, T., Kawano, S., & Tsuji, S. (1995) · Journal of Gastroenterology · doi:10.1007/bf02349653 · Cited by 2
Refractory inflammatory bowel disease
Judge, T. A., & Lichtenstein, G. R. (2001) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-001-0039-x · Cited by 2
THE MANAGEMENT OF REFRACTORY DISTAL COLITIS
Travis, S. P. L. (2001) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.1177/1478271520013103010 · Cited by 2
Fifty years of gastroenterology in Australia
Powell, L. W., Selby, W. S., McCaughan, G. W., & Grimm, M. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01825.x · Cited by 2
Inflammatory bowel diseases: a new wave of therapy
Murthy, S., Flanigan, A., Osborne, B., & Murthy, N. S. (1998) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.8.7.785 · Cited by 2
Unconventional treatments for inflammatory bowel disease
Guslandi, M. (1998) · Current Therapeutic Research · doi:10.1016/s0011-393x(98)85092-3 · Cited by 2
An unusual finding in a patient with iron deficiency anaemia
Leyden, J. E., O’Shea, C., Hegarty, S., & MacMathúna, P. (2005) · Gut · doi:10.1136/gut.2005.067082 · Cited by 1
Novel approaches to inflammatory bowel disease
McKaig, B. C., & Stack, W. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.7.1099 · Cited by 2
Complementary and Alternative Medicine in Gastroenterology
Lembo, A. J., & Bollom, A. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch130 · Cited by 2
Miscellaneous drugs, materials, and medical devices
Choulis, N. H. (2002) · Side effects of drugs annual · doi:10.1016/s0378-6080(02)80056-3 · Cited by 1
Risque de rectocolite hémorragique (RCH) chez les fumeurs actifs et sevrés
Tréton, X. (2011) · Côlon & Rectum · doi:10.1007/s11725-011-0333-2 · Cited by 1
“En effet, les essais thérapeutiques testant la nicotine dans la RCH sont négatifs, avec des taux rédhibitoires d’effets indésirables [14].”
Background
Modulation of neuroimmune axis and treatment of gastrointestinal diseases
Théodorou, V., Eutamène, H., & Vergnolle, N. (2007) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2007.10.005 · Cited by 1
Inflammatory Bowel Disease Part I: Ulcerative Colitis - Pathophysiology and Conventional and Alternative Treatment Options Kathleen A. Head, ND and
Jurenka, J. S. (2003) · Cited by 1
Animal Inhalation Models to Investigate Modulation of Inflammatory Bowel Diseases
Sasso, G. L., Schlage, W. K., Phillips, B. W., Peitsch, M. C., & Hoeng, J. (2018) · InTech eBooks · doi:10.5772/intechopen.69569 · Cited by 1
Possible Therapeutic Role of Cholinergic Agonists on COVID-19 related inflammatory response
Barış, E., & Arıcı, A. (2021) · Journal of Basic and Clinical Health Sciences · doi:10.30621/jbachs.869857 · Cited by 1
EVALUATING THE ACUTE EFFECTS OF CAFFEINATED WATERPIPE TOBACCO IN WATERPIPE USERS
Cobb, C. O. (2012) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/p9ze-3a29 · Cited by 1
Medical treatment of ulcerative colitis.
Dalal, L. (2007) · PubMed · Cited by 1
Influence of Iron Supplementation on Gut Microbiota and the Natural History of Inflammatory Bowel Disease
Mahalhal, A. (2017) · University of Liverpool · doi:10.17638/03009111 · Cited by 1
Clinical pharmacology in inflammatory bowel disease: optimizing current medical therapy
Egan, L. J., & Sandborn, W. J. (2007) · Springer eBooks · doi:10.1007/0-387-25808-6_25 · Cited by 1
“In therapeutic trials for UC, transdermal nicotine has caused considerable side effects [229, 236, 237].”
Background
Oral Mucosal Lesions and Oral Health-Related Quality of Life in Persons Attending a Dermatology Clinic in Khartoum, Sudan
Suliman, N. M. (2013) · NORA - Norwegian Open Research Archives · Cited by 1
Refractory inflammatory bowel disease
Kim, K. H., & Lichtenstein, G. R. (2004) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-004-0041-1 · Cited by 1
“Therapy with the nicotine patch has modest efficacy in mild to moderate ulcerative colitis [ 23 ].”
Background
Gibt es Neues in der Standardtherapie der CED?
Schölmerich, J. (1999) · Der Internist · doi:10.1007/s001080050468 · Cited by 1
Smoking and atherosclerosis
Hospital, C. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)80758-9 · Cited by 1
Ulcerative Colitis
Fonkalsrud, E. W. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-02842-4.50097-8 · Cited by 1
The immune system as the sixth sense
Lalock, J. E. B. (2005) · Cited by 1
Medical Therapy
Hanauer, S. B., & Stein, R. B. (1999) · Springer eBooks · doi:10.1007/978-1-4612-1396-3_7 · Cited by 1
Clinical pharmacology in inflammatory bowel disease: optimizing current medical therapy
Egan, L. J., & Sandborn, W. J. (2003) · Springer eBooks · doi:10.1007/978-1-4020-3477-0_25 · Cited by 1
Ulcerative Colitis
Jewell, D. P., Sutherland, L. R., McDonald, J. W., & Feagan, B. G. (2010) · Wiley eBooks · doi:10.1002/9781444314403.ch12 · Cited by 1
Ulcerative Colitis
Lashner, B. A. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-314-9_29 · Cited by 1
Efeito das fibras alimentares de abobora na inflamação intestinal induzida em ratos
Suzuki, É. (2008) · doi:10.47749/t/unicamp.2008.447874
Caracterização fenotípica e funcional de células dendríticas após vagotomia unilateral cervical em camundongos C57BL/6
da Cruz, D. S. G. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2013.tde-07012014-083924
Entzündliche Erkrankungen des Dickdarms, Anorektums und Perianalbereichs
Stein, E. (2003) · Springer eBooks · doi:10.1007/978-3-642-55594-7_17
Die Neuro-Endokrino-Immunologie der Multiplen Sklerose
Paur, R., & Schmidbauer, M. (2009) · Psychopraxis · doi:10.1007/s00739-009-0153-4
Immunopharmacology of inflammatory bowel disease : effects of glucocorticoids and nicotine on cytokine production
Madretsma, G. S. (1997) · RePub (Erasmus University Rotterdam)
NICOTINE ENEMAS: SMOKE AND MIRRORS IN THE TREATMENT OF ACTIVE ULCERATIVE COLITIS?
Regueiro, M. D. (2006) · Evidence-Based Gastroenterology · doi:10.1097/01.ebg.0000211606.98669.da
Nonorthodox Therapeutic Practices in Inflammatory Bowel Disease
Guslandi, M. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.0854b.x
Human Smoking – Animal Passive Smoking: What Do We Learn from It about Inflammatory Bowel Disease?
Reif, S. S. (2007) · Digestion · doi:10.1159/000112642
IL-12 p40 GENE EXPRESSION: INHIBITORY PATHWAYS AND INFLAMMATORY BOWEL DISEASE
Rao, K. N. (2006) · D-Scholarship@Pitt (University of Pittsburgh)
Getting nervous about IBD
Fulmer, T. (2008) · Science-Business eXchange · doi:10.1038/scibx.2008.396
The puzzling inflammatory bowel disease: growing interest for mediators of inflammation
Zijlstra, F. J. (1997) · Mediators of Inflammation · doi:10.1080/09629359791767
“The adequate therapy of patients not responding to classical treatment with corticosteroids nowadays includes the experimental use of antiTNFa and IL-10 in Crohn’s disease,(7,8) whereas nicotine also has proven to be benecial in ulcerative colitis.(9) Such treatment regimens imply knowledge about mechanisms of action…”
Background
Clinical study on saccharomyces boulardii in the treatment of patients with mild to moderate ulcerative colitis
Tang, H., Wu, H., Mao, J., Zhu, L., Li, N., & Wang, Y.-D. (2014) · International Conference on Control and Automation · doi:10.1109/icca.2014.6871012
“ENDOSCOPY SCORE STANDARD IMPROVED BARON STANDARD[5] SYSTEM”
Inflammatory Intestinal Disorders : Genetic background and consequences of gene-defects on immune activation
Borm, M. E. A. (2007) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Hooked on the nicotine addiction thesis: a response to DiFranza
Dar, R., & Frenk, H. (2013) · Harm Reduction Journal · doi:10.1186/1477-7517-10-31
“bacco does not cause “addiction” [13] and is not self-”
Background
Severity of ulcerative colitis in the study population in Iran in correlation with cigarette consumption
Heydari, G., Tafti, S. F., Alvanpour, A., Talischi, F., Mojhgani, N., Mokri, B., & Hosseini, S. (2010) · International Journal of Medicine and Medical Sciences
The Cholinergic Anti-inflammatory Pathway: Connecting the Mind and Body
Czura, C. J., Friedman, S., & Tracey, K. J. (2006) · Springer eBooks · doi:10.1007/3-540-30328-6_18
“This neurotransmitter receptor system on cells of the innate immune system may explain, at least in part, the therapeutic effects of several cholinergic agonists, including nicotine, which have proven efficacious in inflammatory bowel disease [ 4 ].”
Background
Transdermal Medications: Why Bother?
Kuritzky, L. (1995) · Hospital Practice · doi:10.1080/21548331.1995.11443223
Biological markers demonstrate utility and predictive value in inflammatory bowel disease
Morris, M. W. (2015) · University Library - University of Saskatchewan (University of Saskatchewan)
Diagnostik und Therapie bei verifizierten chronisch entzündlichen Darmerkrankungen
Aichbichler, B. W., Hinterleitner, T., & Petritsch, W. (1995) · European surgery. Supplement/European surgery · doi:10.1007/bf02602266
New Concepts of Pathogenesis in Inflammatory Bowel Disease
Fiocchi, C. (1995) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/1995/847312
“However, a study just published shows that the addition of transdermal nicotine to conventional treatment significantly improves symptoms in UC patients (114).”
Background
Ulcerative colitis
Saubermann, L. J. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-0317-5.50063-7
INFLAMMATORY BOWEL DISEASES: Genetic Markers and their Use in Predicting Disease Course, Response to Treatment, and Need for Surgery
Fischer, S., & Lakatos, P. L. (2008)
MEDICAL TREATMENT OF ULCERATIVE COLITIS AND OTHER COLITIDES
Lashner, B. A., & Brzezinski, A. (2005) · Elsevier eBooks · doi:10.1016/b978-1-55664-480-1.50041-1
Smoking, Implications of
Evans, W., & WRIGHT, R. A. (2004) · Encyclopedia of Gastroenterology · doi:10.1016/b0-12-386860-2/00655-9
Inflammatory Bowel Disease: Smoking Status and Is There Any Relation Between Disease Presentation?
Rüssel, M. G., Volovics, A., Schoon, E. J., Logan, R. F., Shivananda, S., & Stockbriigger, R. W. (1998)
Inflammatory bowel disease: dysfunction ofGALT and gut bacterial flora (IT)
Chandran, P., Satthaporn, S., Robins, A., & Eremin, O. (2003)
Perinatal asphyxia and intervention: possible neuroprotective effects of intravenous nicotine administration. An experimental study in newborn piglets
Andresen, J. H. (2008)
Medical management of ulcerative colitis
Sandborn, W. J. (2003) · Springer eBooks · doi:10.1007/978-1-4020-3477-0_30
Principles of Medical Management of Ulcerative Colitis
Vu, H. T., & Dassopoulos, T. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1677-1_4
Current Medical Therapies for Ulcerative Colitis
Cheah, M., & Khanna, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809402-0.00001-0
Symptomatic Effects of Smoking in Ulcertive Colitis: A Clinical Dilemma
Jain, Y., & Singh, A. (2018) · Journal of Inflammatory Bowel Diseases & Disorders · doi:10.4172/2476-1958.1000129
Nicotine replacement therapy
(2006) · Elsevier eBooks · doi:10.1016/b0-44-451005-2/01184-0
Chronische Schmerzen und Fatigue bei chronisch-entzündlichen Darmerkrankungen
Sonnenberg, E., & Biedermann, L. (2019) · Die Gastroenterologie · doi:10.1007/s11377-019-00389-8
Mecanismos de control neuroinmune y la vía colinérgica antiinflamatoria
Pérez-Cervera, Y., & Rosas, R. T. (2018) · Tequio · doi:10.53331/teq.v1i2.9987
Ulcerative Colitis
Jewell, D. P., & Sutherland, L. R. (2004) · Wiley eBooks · doi:10.1002/9780470987025.ch11
Bibliographie
Motulsky, H. (2019) · De Boeck Supérieur eBooks · doi:10.3917/dbu.motul.2019.01.0533
Nicotine Modulates Innate Immune Pathways via α7 Nicotinic Acetylcholine Receptor
Li, M. D. (2018) · Springer eBooks · doi:10.1007/978-981-10-7530-8_16
Nicotine and Inflammatory Disease in Humans: A Systematic Review
Price, L. R., Thompson, K., & Martinez, J. (2022) · Contributions to Tobacco & Nicotine Research · doi:10.2478/cttr-2022-0002
Entzündliche Erkrankungen des Dickdarms, Anorektums und Perianalbereichs
Stein, E. (1998) · Springer eBooks · doi:10.1007/978-3-642-97707-7_17
AETIOLOGY, PATHOLOGY AND MEDICAL ASPECTS OF ULCERATIVE COLITIS
(2008) · Elsevier eBooks · doi:10.1016/b978-0-7020-2723-9.50040-3
Miscellaneous drugs, materials, and medical devices
Choulis, N. H. (1995) · Side effects of drugs annual · doi:10.1016/s0378-6080(05)80174-6
Neural Regulation of Interactions between Group 2 Innate Lymphoid Cells and Pulmonary Immune Cells
Chen, W., Shu, Q., & Fan, J. (2021) · Vide Leaf, Hyderabad eBooks · doi:10.37247/paimmu2ed.2.2021.5
Therapeutic strategy in ulcerative colitis — 2004
Rachmilewitz, D. (2007) · Springer eBooks · doi:10.1007/1-4020-2912-8_29
Medikamentöse Therapie der Colitis ulcerosa
Adler, G. (1996) · Springer eBooks · doi:10.1007/978-3-642-61023-3_18
ULCERATIVE PROCTITIS
(2008) · Elsevier eBooks · doi:10.1016/b978-0-7020-2723-9.50041-5
Smoking
Benoni, C. (1994) · Springer eBooks · doi:10.1007/978-94-009-0371-5_33
Nicotine and nicotine replacement therapy
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01145-8
Compounds found in Herbal products
(2009) · Elsevier eBooks · doi:10.1016/b978-0-444-53269-5.50006-6
Rectites réfractaires
Seksik, P., Daniel, F. E., Marteau, P. R., Beaugerie, L., & Cosnes, J. (2007) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(07)89398-5
What is the impact of nicotine on the Post-COVID-19 syndrome - a severe impairment of acetylcholine-orchestrated neuromodulation: A case seriesPreprint
Leitzke, M. (2022) · Research Square · doi:10.21203/rs.3.rs-2063399/v1
Drug Information Rounds
(1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603000918
Uveitic Complications Associated with Smoking StatusPreprint
Samalia, P. D., Kang, G., Sims, J. L., & Niederer, R. L. (2023) · Research Square · doi:10.21203/rs.3.rs-2641176/v1
The relationship between the severity of inflammatory bowel diseases and expirium air carbon monoxide levels
Yalçın, B. M., Ustaoğlu, M., & Kıraç, Y. (2023) · International Journal of Colorectal Disease · doi:10.1007/s00384-023-04468-9
“Among these therapies, nicotine gum and transdermal patches which directly increase nicotine levels in circulation have been described as more successful in controlling colitis, despite their side effects [37].”
Additional file 2 of Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease
Zanussi, J., Zhao, J., Wei, W., Karakoc, G., Chung, C. P., Feng, Q., Olsen, N. J., Stein, C. M., & Kawai, V. K. (2023) · Figshare · doi:10.6084/m9.figshare.23902813
THE EFFECT OF SMOKING ON ULCERATIVE COLITIS - A REVIEW ARTICLE
Knutelska, K., Jędrzejewska-Rzezak, P., Czekalska, M., Kulicka, N., Winsyk, A., Gajniak, P., Karwat, M., Tyralik, T., Bilińska, K., & Węgrzecka, J. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3634
Nicotine-quercetin combination alleviate ulcerative colitis via PI3K/AKT and NF-κB pathway inhibition
Ma, H., Wang, H., Chen, H., Hou, H., & Hu, Q. (2025) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/csb-2025-5305
Additional file 2 of Is the post-COVID-19 syndrome a severe impairment of acetylcholine-orchestrated neuromodulation that responds to nicotine administration?
Leitzke, M. (2024) · Figshare · doi:10.6084/m9.figshare.26560283
Additional file 4 of Is the post-COVID-19 syndrome a severe impairment of acetylcholine-orchestrated neuromodulation that responds to nicotine administration?
Leitzke, M. (2024) · Figshare · doi:10.6084/m9.figshare.26560289
Additional file 1 of Is the post-COVID-19 syndrome a severe impairment of acetylcholine-orchestrated neuromodulation that responds to nicotine administration?
Leitzke, M. (2024) · Figshare · doi:10.6084/m9.figshare.26560280
Additional file 3 of Is the post-COVID-19 syndrome a severe impairment of acetylcholine-orchestrated neuromodulation that responds to nicotine administration?
Leitzke, M. (2024) · Figshare · doi:10.6084/m9.figshare.26560286
Additional file 1 of Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease
Zanussi, J., Zhao, J., Wei, W.-Q., Karakoc, G., Chung, C. P., Feng, Q., Olsen, N. J., Stein, C. M., & Kawai, V. K. (2023) · Figshare · doi:10.6084/m9.figshare.23902807

Authors: Pullan, R. D., Rhodes, J., Ganesh, S., Mani, V., Morris, J. S., Williams, G. T., Newcombe, R. G., Russell, M., Feyerabend, C., Thomas, G., & Sawe, U.
Affiliations: University Hospital of Wales (GB)
University of Wales (GB)
Princess of Wales Hospital (GB)
New Cross Hospital (GB)
ORCID: Newcombe, Robert G.
Thomas, Gareth
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1994-03-24
Volume: 330
Issue: 12
Pages: 811-815
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199403243301202
OpenAlex: W2315418290
Cited by: 505
References: 28
Citations by year: 2026: 3 · 2025: 6 · 2024: 9 · 2023: 11 · 2022: 10 · 2021: 10 · 2020: 20 · 2019: 9 · 2018: 14 · 2017: 7 · 2016: 5 · 2015: 11 · 2014: 14 · 2013: 15 · 2012: 9
FWCI: 15.58
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
Keywords: ulcerative colitis, transdermal nicotine, nicotine patch, smoking, nicotine withdrawal, 5-aminosalicylic acid, maintenance therapy, remission, symptom improvement, adverse effects
MeSH terms: Administration, Cutaneous, Adult, Affect, Colitis, Ulcerative, Cotinine, Double-Blind Method, Female, Humans, Male, Middle Aged, Nicotine, Treatment Outcome, Drug Monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Transdermal Nicotine for Active Ulcerative Colitis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks